Results 1–20 of 44 for liothyronine

Written Answers — Department of Health and Social Care: Liothyronine: Prices (15 Jan 2019)

Jim Shannon: To ask the Secretary of State for Health and Social Care, what discussions he has had with pharmaceutical companies on reducing the cost of the drug liothyronine.

Written Answers — Department of Health and Social Care: Liothyronine (20 Dec 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what action they are taking to negotiate a reduction of the cost of liothyronine (T3) for use in primary care.

Scottish Parliament: Thyroid and Adrenal Testing, Diagnosis and Treatment (4 Dec 2018)

Elaine Smith: ...important aspect for those needing it to survive: “The Scottish Government’s position is that treatment for Hypothyroidism in Scotland should be consistent with the BTA guidance in relation to Liothyronine (T3) and clinicians in Scotland can prescribe T3 where it is safe and clinically appropriate, on the advice of a consultant in endocrinology.” The minister backed that up in his...

Scottish Parliament: Women’s Health (Obesity) (27 Sep 2018)

Elaine Smith: ...disorders? Does she agree that it is unacceptable for any Scottish national health service board to refuse patients, particularly those under the care of an endocrinologist, their prescriptions for liothyronine medication, as currently happens? Will she ask the Cabinet Secretary for Health and Sport to intervene to ensure that my constituents and other thyroid sufferers are not stopped by...

Written Answers — Department of Health and Social Care: Liothyronine (11 Sep 2018)

Layla Moran: To ask the Secretary of State for Health and Social Care, what recent steps he has taken to increase access to liothyronine on the NHS for people with hypothyroidism.

Written Answers — Department of Health and Social Care: Liothyronine (11 Sep 2018)

Steve McCabe: ...and Social Care, what discussions his Department has had with the Competition and Markets Authority on the publication of the final outcome of the investigation into Concordia and their pricing of Liothyronine (T3) medication.

Written Answers — Department of Health and Social Care: Liothyronine (26 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government whether they will commission research on the impact of the withdrawal of liothyronine (T3) and its subsequent replacement with T4 on (1) the health and well being of patients, and (2) the cost to the NHS.

Written Answers — Department of Health and Social Care: PrescQIPP (26 Jul 2018)

Lord O'Shaughnessy: ...by PrescQIPP. Nor have we made any assessment on whether the advice provided by PrescQIPP to clinical commissioning groups (CCGs) is consistent with national guidelines on the prescription of liothyronine to National Health Service patients. We can confirm that we have not received any assurances from PrescQIPP on whether or not it has taken patient stakeholder views into account as it is...

Written Answers — Department of Health and Social Care: Liothyronine (25 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 4 July (HL8857), whether patient groups were consulted in relation to the discussions on Liothyronine (T3) at the meetings of the Regional Medicines Optimisation Committee held in January and May 2018.

Written Answers — Department of Health and Social Care: Liothyronine (25 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what assessment they have made of the risk to patients of being denied access to liothyronine (T3) where they had previously achieved good health outcomes when using the medicine.

Written Answers — Department of Health and Social Care: Liothyronine (25 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government whether they intend to review local and regional guidance by NHS bodies which do not follow current national guidance in relation to the prescribing of liothyronine (T3).

Written Answers — Department of Health and Social Care: Liothyronine (25 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government whether they will ensure that the appropriate funds will be made available when an endocrinologist has prescribed liothyronine (T3) for an NHS patient.

Written Answers — Department of Health and Social Care: Liothyronine (25 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government whether they will take steps to withdraw PrescQIPP guidance to Clinical Commissioning Groups in the East of England on prescribing liothyronine (T3) as it has not been updated to reflect current national guidelines.

Written Answers — Department of Health and Social Care: Liothyronine (23 Jul 2018)

Lord Hunt of Kings Heath: ...July (HL8980, HL8981, HL8982 and HL8983), what action they are taking to ensure that NHS England makes clear to Clinical Commissioning Groups that the national guidelines on access for patients to Liothyronine (T3) are expected to be fully followed.

Written Answers — Department of Health and Social Care: Liothyronine (23 Jul 2018)

Lord Hunt of Kings Heath: ...to the Written Answer by Lord O'Shaughnessy on 4 July (HL8854), why the minutes of the meeting of the Regional Optimisation Committee South held in May 2018 in relation to the discussion on Liothyronine (T3) have yet to be published.

Written Answers — Department of Health and Social Care: Liothyronine (10 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what action they propose to ensure that the Brighton and Sussex University Hospitals NHS Trust withdraws its policy of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.

Written Answers — Department of Health and Social Care: Liothyronine (4 Jul 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government whether they have held discussions with NHS England about why NHS bodies in Wessex are developing guidelines on the use of liothyronine which are at variance with national guidelines issued by NHS England.

Branded Health Service Medicines (Costs) Regulations 2018 - Motion to Regret (20 Jun 2018)

Lord O'Shaughnessy: .... The drug levothyroxine, T4, is beneficial for the majority of patients with hypothyroidism, as we have heard, but it does not treat the condition in all patients. For some, the alternative drug, liothyronine, commonly known as T3, which is the subject of this evening’s debate, is a treatment which better alleviates their symptoms. NHS England has set out that liothyronine should be...

Delegated Legislation: Hypothyroidism (21 May 2018)

Steve Brine: ...for the majority of patients with the condition but does not treat the condition in all patients. For some, the alternative drug at the centre of the right hon. Gentleman’s opening remarks—liothyronine—better alleviates symptoms. Let me say up front that, if people have a clinical need for a medicine, it is right that they get the most appropriate medicine for their condition. It is...

Written Answers — Department of Health and Social Care: Thyroid Diseases: Drugs (17 May 2018)

Steve Brine: ...dispensed in the community in England British National Formulary Chemical Name 2015 2016 2017 Levothyroxine Sodium £104,482,222 £97,074,190 £86,942,415 Levothyroxine Sodium and Liothyronine £665,394 £1,000,049 £1,270,675 Liothyronine Sodium £22,188,778 £32,804,312 £30,237,512 Total £127,336,394 £130,878,552 £118,450,601 Source: Prescription Cost...


1 2 3 > >>

Create an alert

Did you find what you were looking for?

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.